ABVC BioPharma, Inc. Operating Lease, Right-of-Use Asset, Amortization Expense
ABVC BioPharma, Inc. (ABVC) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $169.35 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2026-08-12
- ABVC BioPharma, Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-06-30 was $82.98K, a 11.93% increase year-over-year.
- ABVC BioPharma, Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-03-31 was $86.37K, a 19.22% decline year-over-year.
- ABVC BioPharma, Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-12-31 was $208.25K.
- ABVC BioPharma, Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-09-30 was $90.19K, a 9.21% decline year-over-year.
- ABVC BioPharma, Inc. operating lease, right-of-use asset, amortization expense for fiscal 2025 was $479.50K, a 183.90% increase from fiscal 2024.
- ABVC BioPharma, Inc. operating lease, right-of-use asset, amortization expense for fiscal 2024 was $168.90K, a 52.00% decline from fiscal 2023.
- ABVC BioPharma, Inc. operating lease, right-of-use asset, amortization expense for fiscal 2023 was $351.86K.
- ABVC BioPharma, Inc. operating lease, right-of-use asset, amortization expense for fiscal 2021 was $1.47M.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month | Operating Lease, Right-of-Use Asset, Amortization Expense 9 month | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $82.98K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $169.35K 10-Q · filed 2026-08-12 | $377.60K derived: sum of 3 quarters · filed 2026-08-12 | $467.79K derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $86.37K 10-Q · filed 2026-05-18 | $294.63K derived: sum of 2 quarters · filed 2026-05-18 | $384.81K derived: sum of 3 quarters · filed 2026-05-18 | $458.95K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $208.25K derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-03-03 | $298.44K derived: sum of 2 quarters · filed 2026-03-03 | $372.58K derived: sum of 3 quarters · filed 2026-08-12 | $479.50K 10-K · filed 2026-03-03 |
| 2025-09-30 | $90.19K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2026-03-03 | $164.32K derived: sum of 2 quarters · filed 2026-08-12 | $271.25K 10-Q/A · filed 2026-03-03 | $138.52K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | $74.14K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $181.06K 10-Q · filed 2026-08-12 | $48.33K derived: sum of 3 quarters · filed 2026-08-12 | $147.68K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $106.93K 10-Q · filed 2026-05-18 | -$25.80K derived: sum of 2 quarters · filed 2026-05-18 | $73.54K derived: sum of 3 quarters · filed 2026-05-18 | $174.56K derived: sum of 4 quarters · filed 2026-05-18 |
| 2024-12-31 | -$132.73K derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-03-03 | -$33.39K derived: sum of 2 quarters · filed 2026-03-03 | $67.64K derived: sum of 3 quarters · filed 2026-03-03 | $168.90K 10-K · filed 2026-03-03 |
| 2024-09-30 | $99.34K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2026-03-03 | $200.36K derived: sum of 2 quarters · filed 2026-03-03 | $301.62K 10-Q/A · filed 2026-03-03 | |
| 2024-06-30 | $101.02K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $202.28K 10-Q · filed 2025-08-13 | ||
| 2024-03-31 | $101.26K 10-Q · filed 2025-04-30 | |||
| 2023-12-31 | $351.86K 10-K · filed 2025-04-15 | |||
| 2023-06-30 | -$99.11K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $999.64K 10-Q · filed 2023-08-14 | $916.86K derived: sum of 3 quarters · filed 2023-08-14 | $866.24K derived: sum of 4 quarters · filed 2023-08-14 |
| 2023-03-31 | $1.10M 10-Q · filed 2023-05-15 | $1.02M derived: sum of 2 quarters · filed 2023-08-14 | $965.35K derived: sum of 3 quarters · filed 2023-08-14 | $877.21K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-12-31 | -$82.79K derived: 10-Q 12 month − 10-Q 9 month · filed 2023-08-14 | -$133.41K derived: sum of 2 quarters · filed 2023-08-14 | -$221.55K derived: sum of 3 quarters · filed 2023-08-14 | $1.16M 10-Q · filed 2023-08-14 |
| 2022-09-30 | -$50.62K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$138.76K derived: sum of 2 quarters · filed 2022-11-14 | $1.24M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | -$88.14K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $1.29M 10-Q · filed 2022-08-15 | ||
| 2022-03-31 | $1.38M 10-Q · filed 2022-05-16 | |||
| 2021-12-31 | $1.47M 10-K · filed 2023-03-31 |